GLOBAL EXPERIENCE AND PROSPECTS OF THE APPLICATION OF ARTIFICIAL INTELLIGENCE IN THE EDUCATIONAL PROCESS AND IN PHARMACEUTICAL PRACTICE
DOI:
https://doi.org/10.11603/m.2414-5998.2024.1.14582Keywords:
artificial intelligence, pharmaceutical sciences, educationAbstract
The pharmaceutical industry of modern Ukraine occupies a significant place in the country's economy and is characterised by significant research intensity and stable growth rates. The realities of the pharmaceutical market today include an increasing variety of services that are provided in a specific pharmacy organisation and are becoming clinically oriented and require additional specialised training of pharmacists. High professionalism and experience of specialists is an important factor in maintaining and developing the industry. Moreover, professionalism should be present in the financial and economic department of the company, in the elements of pharmaceutical management and marketing of the pharmacy, as well as in technological innovations, which are being actively introduced into the healthcare system.
The introduction of artificial intelligence (AI) into the pharmaceutical industry has changed the processes of drug discovery, development, manufacturing, clinical trials and marketing. The capabilities of AI range from increasing accuracy and minimizing errors to realizing previously impossible new ideas. Over the last decade, pharmaceutical research has shifted its paradigm towards artificial intelligence-based research. The pharmaceutical industry uses AI in drug development, drug design optimization and many other processes, saving time, money and reducing risks in the form of complications, unwanted side effects for patients during administration new medicines. AI-based manufacturing automation simplifies the process, improves quality control, and optimizes production parameters. The application of AI algorithms to verify diseases and predict test results is very promising for patient treatment.
Thus, in the new era of pharmaceutical practice and education, the curricula of higher pharmacy schools should promote the development of specific competencies for the cognitive, conscious and effective use of digital tools.
References
Nakaz Ministerstva osvity i nauky Ukrainy Pro zatverdzhennia standartu vyshchoi osvity zi spetsialnosti 226 Farmatsiia, promyslova farmatsiia dlia druhoho (mahisterskoho) rivnia vyshchoi osvity vid 04.11.2022 r. № 981 [Order of the Ministry of Education and Science of Ukraine On Approval of the Standard of Higher Education in the Specialty 226 Pharmacy, Industrial Pharmacy for the Second (Masterʼs) Level of Higher Education dated 04.11.2022 No. 981] [in Ukrainian].
Baek, M., DiMaio, F., Anishchenko, I., Dauparas, J., Ovchinnikov, S., Lee, G.R., … Baker, D. (2021). Accurate prediction of protein structures and interactions using a 3-track neural network. Science, 373(6557), 871-876.
Stokes, M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N.M., … Collins, J.J. (2020). A Deep Learning Approach to Antibiotic Discovery. Science Direct, 180(4), 688-702.
Chan, H.S., Shan, H., Dahoun, T., Vogel, H., & Yuan, S. (2019). Advancing drug discovery via artificial intelligence. Trends in pharmacological sciences, 40(8), 592-604.
Bhinder, B., Gilvary, C., Madhukar, N.S., & Elemento, O. (2021). Artificial intelligence in cancer research and precision medicine. Cancer Discovery, 11(4), 900-915.
Aungst, T.D., & Patel, R. (2020). Integrating Digital Health into the Curriculum-Considerations on the Current Landscape and Future Developments. Journal of Medical Education and Curricular Development, 7.
Basile, A.O., Yahi, A., & Tatonetti, N.P. (2019). Artificial intelligence for drug toxicity and safety. Trends in pharmacological sciences, 40(9), 624-635.
Burki, T. (2020). A new paradigm for drug development. The Lancet Digital Health, 2(5), e226-e227.
Cui, W., Aouidate, A., Wang, S., Qiuliyang, Yu., Li, Y., & Yuan, S. (2020). Discovering Anti-Cancer Drugs via Computational Methods. Frontiers in Pharmacology, 11, 733. Retrieved from: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.00733/full.
Farghali, H., Canová, N.K., & Arora, M. (2021). The Potential Applications of Artificial Intelligence in Drug Discovery and Development. Physiol. Res., 70(4), S715-S722.
International Pharmaceutical Federation (FIP) (2021). FIP Digital Health in Pharmacy Education. Retrieved from: https://www.fip.org/file/4958.
Zhang, L., Tan, J., Han, D., & Zhu, H. (2017). From machine learning to deep learning: progress in machine intelligence for rational drug discovery. Drug discovery today, 22(11), 1680-1685.
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., … Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. Naturale, 596(7873), 583-589. Retrieved from: https://www.nature.com/articles/s41586-021-03819-2%3C.
Hinkson, I.V., Madej, B., & Stahlberg, E.A. (2020). Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery. Frontiers in Pharmacology, 11, 770. Retrieved from: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.00770/full.
Sumitomo Dainippon Pharma (2020). Major products under development. Retrieved from: https://www.ds-pharma.com/ir/library/annual/pdf/2020/eng114.pdf.
(2019). Intelligent drug discovery. A report from the Deloitte Centre for Health Solutions. Retrieved from: https://www2.deloitte.com/content/dam/Deloitte/ch/Documents/life-sciences-health-care/deloitte-ch-en-intelligent-drug-discovery.pdf.
Hughes, T.B., Flynn, N., Dang, N.L., & Swamidass, S.J. (2021). Modeling the Bioactivation and Subsequent Reactivity of Drugs. Chem. Res. Toxicol., 34(2), 584-600.
Najafi, S. (2020). The use of AI on drug testing. International Journal of Modern Engineering Technologies, 2(1).
Porumb, M., Stranges, S., Pescapè, A., & Pecchia, L. (2020). Precision medicine and artificial intelligence: a pilot study on deep learning for hypoglycemic events detection based on ECG. Scientific reports, 10(1), 1-16.
Schneider, P., Walters, W.P., Plowright, A.T., Sieroka, N., Listgarten, J., Goodnow Jr., R.A., … Schneider, G. (2020). Rethinking drug design in the artificial intelligence era. Nat. Rev. Drug Discov. Retrieved from: https://discovery.ucl.ac.uk/id/eprint/10089268/3/Fisher%20RETHINK_manuscript_14Sep2019_final.pdf.
Sangave, N.A., & Cheung, Ch. (2022). Artificial Intelligence Applications in Education and Pharmacy Practice. Retrieved from: https://www.pharmacytimes.com/view/artificial-intelligence-applications-in-education-and-pharmacy-practice.
Smalley, E. (2017). AI-powered drug discovery captures pharma interest. Nature Biotechnology, 35(7), 604-606.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Medical Education
This work is licensed under a Creative Commons Attribution 4.0 International License.
